Related Experiment Videos
Ga-67 citrate accumulation in adenomatous goiter
S Miyamoto1, K Kasagi, R Takeuchi
1Department of Nuclear Medicine, Kyoto University, Japan.
Clinical Nuclear Medicine
|October 1, 1992
Summary
Gallium-67 (Ga-67) citrate uptake was observed in adenomatous goiter, a previously unreported finding. This case highlights the potential for Ga-67 imaging to reveal unexpected thyroid abnormalities alongside malignancy.
Area of Science:
- Nuclear medicine
- Oncology
- Endocrinology
Background:
- Gallium-67 (Ga-67) citrate is a radiopharmaceutical primarily used for imaging tumors and infections.
- Thyroid nodules and goiters are common, with varying degrees of malignancy risk.
- Ga-67 uptake in the thyroid is typically associated with malignancy, such as thyroid cancer.
Observation:
- An elderly woman presented with a diffusely enlarged goiter and miliary nodular lesions on chest X-ray.
- Ga-67 scintigraphy revealed abnormal accumulation in the right thyroid lobe.
- Histopathology confirmed papillary thyroid carcinoma in the left lobe with pulmonary metastases and benign adenomatous nodules in the right lobe.
Findings:
- This case is the first documented instance of Ga-67 accumulation in adenomatous goiter.
- The findings suggest that Ga-67 uptake is not exclusively indicative of thyroid malignancy.
- Concurrent papillary thyroid carcinoma with pulmonary metastases was diagnosed in the contralateral lobe.
Implications:
- Ga-67 scintigraphy findings in the thyroid require careful interpretation, considering the possibility of benign conditions.
- The study expands the understanding of Ga-67 radiopharmaceutical behavior in the thyroid gland.
- Further research may be warranted to elucidate the mechanisms of Ga-67 uptake in adenomatous thyroid tissue.